Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

373 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model.
Llopiz D, Ruiz M, Villanueva L, Iglesias T, Silva L, Egea J, Lasarte JJ, Pivette P, Trochon-Joseph V, Vasseur B, Dixon G, Sangro B, Sarobe P. Llopiz D, et al. Among authors: villanueva l. Cancer Immunol Immunother. 2019 Mar;68(3):379-393. doi: 10.1007/s00262-018-2283-0. Epub 2018 Dec 13. Cancer Immunol Immunother. 2019. PMID: 30547218 Free PMC article.
Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin.
Mansilla C, Berraondo P, Durantez M, Martínez M, Casares N, Arribillaga L, Rudilla F, Fioravanti J, Lozano T, Villanueva L, Sarobe P, Borrás F, Leclerc C, Prieto J, Lasarte JJ. Mansilla C, et al. Among authors: villanueva l. Int J Cancer. 2012 Aug 1;131(3):641-51. doi: 10.1002/ijc.26412. Epub 2011 Oct 5. Int J Cancer. 2012. PMID: 21898393
A fusion protein between streptavidin and the endogenous TLR4 ligand EDA targets biotinylated antigens to dendritic cells and induces T cell responses in vivo.
Arribillaga L, Durantez M, Lozano T, Rudilla F, Rehberger F, Casares N, Villanueva L, Martinez M, Gorraiz M, Borrás-Cuesta F, Sarobe P, Prieto J, Lasarte JJ. Arribillaga L, et al. Among authors: villanueva l. Biomed Res Int. 2013;2013:864720. doi: 10.1155/2013/864720. Epub 2013 Sep 5. Biomed Res Int. 2013. PMID: 24093105 Free PMC article.
Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection.
Zabaleta A, D'Avola D, Echeverria I, Llopiz D, Silva L, Villanueva L, Riezu-Boj JI, Larrea E, Pereboev A, Lasarte JJ, Rodriguez-Lago I, Iñarrairaegui M, Sangro B, Prieto J, Sarobe P. Zabaleta A, et al. Among authors: villanueva l. Mol Ther Methods Clin Dev. 2015 Mar 11;2:15006. doi: 10.1038/mtm.2015.6. eCollection 2015. Mol Ther Methods Clin Dev. 2015. PMID: 26029717 Free PMC article.
Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation.
Lozano T, Villanueva L, Durántez M, Gorraiz M, Ruiz M, Belsúe V, Riezu-Boj JI, Hervás-Stubbs S, Oyarzábal J, Bandukwala H, Lourenço AR, Coffer PJ, Sarobe P, Prieto J, Casares N, Lasarte JJ. Lozano T, et al. Among authors: villanueva l. J Immunol. 2015 Oct 1;195(7):3180-9. doi: 10.4049/jimmunol.1402997. Epub 2015 Aug 31. J Immunol. 2015. PMID: 26324768
Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens.
Arribillaga L, Echeverria I, Belsue V, Gomez T, Lozano T, Casares N, Villanueva L, Domingos-Pereira S, Romero PJ, Nardelli-Haefliger D, Hervás-Stubbs S, Sarobe P, Rodriguez MJ, Carrascosa JL, Zürcher T, Lasarte JJ. Arribillaga L, et al. Among authors: villanueva l. J Immunother Cancer. 2020 Jun;8(1):e000704. doi: 10.1136/jitc-2020-000704. J Immunother Cancer. 2020. PMID: 32581060 Free PMC article.
373 results